CV Sciences, Inc. Appoints Dr. Amy M. McCord as Director of Drug Development
July 11, 2017 at 06:15 pm IST
Share
CV Sciences, Inc. announced it has appointed Amy M. McCord, Ph.D., RAC as Director of Drug Development. With over ten years expertise in regulatory affairs, Dr. McCord will be responsible for the pharmaceutical development and compliance pathway for the Company's drug candidate, CVSI-007, for the treatment of smokeless tobacco addiction. Prior to her work in regulatory affairs, she conducted academic research in cancer biology and microbiology as a scientist at Moffitt Cancer Center and USF. Dr. McCord has also authored several peer-reviewed manuscripts and abstracts presented at national meetings including the American Society of Clinical Oncology and the American Society of Hematology.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
CV SCIENCES, INC. 
